quinazolines has been researched along with hydralazine in 59 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 54 (91.53) | 18.7374 |
| 1990's | 1 (1.69) | 18.2507 |
| 2000's | 4 (6.78) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kellaway, GS | 1 |
| Petrie, JC | 1 |
| Wilson, CL; Zacest, R | 1 |
| Halawa, B | 1 |
| Avery, GS; Brogden, RN; Heel, RC; Speight, TM | 1 |
| Buzzeo, LA; Lowenstein, J; Steele, JM | 1 |
| Kincaid-Smith, P | 1 |
| Fang, P; Hua, A; Kincaid-Smith, P; Laver, MC; Macdonald, IM | 1 |
| Romankiewicz, JA | 1 |
| Fang, P; Hua, AS; Kincaid-Smith, P; Macdonald, IM; Myers, JB | 1 |
| Hua, AS; Kincaid-Smith, P; Myers, JB | 1 |
| Andersson, KE; Mikkelsen, E; Pedersen, OL | 1 |
| Arnold, S; Brundage, B; Chatterjee, K; Parmley, W; Ports, TA | 1 |
| Conti, CR; Iacona, M; Mehta, J; Pepine, CJ | 1 |
| Cartheuser, CF; Komarek, J | 1 |
| Amsterdam, EA; DeMaria, AN; Laslett, LJ; Mason, DT | 1 |
| Rasmussen, K | 1 |
| Jensen, HA; Rasmussen, K | 2 |
| Graham, RM; Oates, HF; Stokes, GS | 1 |
| Fang, P; Hua, AS; Kincaid-Smith, P; MacDonald, I; Myers, JB | 1 |
| Hayden, ML; Massingham, R | 1 |
| Constantine, JW; Hess, HJ; McShane, WK; Scriabine, A | 1 |
| Hua, A; Kincaid-Smith, P | 1 |
| Bing, RF; Russell, GI; Swales, JD; Swart, S; Thurston, H | 1 |
| Andrews, V; Fishman, AP; Janicki, JS; Kinasewitz, GT; Weber, KT | 1 |
| Packard, RS | 1 |
| Romankiewicz, N | 1 |
| Barnes, JN; Drew, PJ; Sharman, VL; Vandenburg, MJ; Wright, P | 1 |
| Feldman, R | 1 |
| Boucek, MM; Chang, R; Synhorst, DP | 1 |
| Jounela, AJ; Karppanen, H; Salmela, PI | 1 |
| Fagerberg, SE; Frithz, G; Malmberg, L | 1 |
| Khomenko, VL; Pomerantsev, VP; Vasiuk, IuA | 1 |
| Cohn, JN | 1 |
| Rutishauser, W | 1 |
| Dyer, RD; Huttner, JJ; Mulrow, PJ; Tan, SY | 1 |
| Melkild, A | 1 |
| Benge, W; Chatterjee, K; Hiramatsu, B; Parmley, WW; Rouleau, JL | 1 |
| Gasanova, AS; Serbin, VI | 1 |
| Bing, RF; Heagerty, AM; Russell, GI; Swales, JD; Thurston, H | 1 |
| Persson, B; Thorén, P; Yao, T | 1 |
| Elkayam, U; Frishman, W; LeJemtel, T; Mathur, M; Sonnenblick, EH; Strom, J | 1 |
| Bay, WH; Desch, CE; Leier, CV; Magorien, RD; Triffon, DW; Unverferth, DV | 1 |
| Atkins, FL | 1 |
| Chatterjee, K; Parmley, WW; Rubin, SA | 1 |
| Greenberg, BH; Massie, BM | 1 |
| Cabaniss, CD | 1 |
| Despas, P; Fitchett, DH; Pardy, R; Pathé, M | 1 |
| Jones, JV; Steiner, JM | 1 |
| Boudoulas, H; Desch, CE; Leier, CV; Lewis, RP; Magorien, RD; Triffon, DW; Unverferth, DV | 1 |
| Himmler, FC; Klein, G; Kutschera, I; Sauer, E; Schmidt, G; Wirtzfeld, A | 1 |
| Dousa, TP; Grande, JP; Johnson, RJ; Shankland, SJ; Tsuboi, Y; Walker, HJ | 1 |
| Higaki, J; Kamide, K; Moriguchi, K; Nagai, M; Ogihara, T; Ohishi, M; Okamura, A; Rakugi, H; Satoh, N; Tuck, ML | 1 |
| Wadman, M | 1 |
| Branca, MA | 1 |
| Duster, T | 1 |
8 review(s) available for quinazolines and hydralazine
| Article | Year |
|---|---|
[Use of vasodilator agents in circulatory insufficienty].
Topics: Blood Circulation; Dihydralazine; Heart Failure; Humans; Hydralazine; Nitrates; Nitroglycerin; Nitroprusside; Prazosin; Quinazolines; Vasodilator Agents | 1979 |
Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension.
Topics: Animals; Benzothiadiazines; Blood Pressure; Clinical Trials as Topic; Diuretics; Drug Eruptions; Drug Therapy, Combination; Heart Rate; Humans; Hydralazine; Hypertension; Kidney; Kidney Diseases; Kinetics; Methyldopa; Prazosin; Quinazolines; Renin; Sodium Chloride Symporter Inhibitors; Time Factors | 1977 |
Vasodilator and inotropic agents in treatment of chronic cardiac failure: clinical experience and response in exercise performance.
Topics: Aerobiosis; Aminopyridines; Amrinone; Anaerobiosis; Cardiotonic Agents; Heart Failure; Hemodynamics; Humans; Hydralazine; Neurotransmitter Agents; Physical Exertion; Piperazines; Quinazolines; Sympathetic Nervous System; Vasodilator Agents | 1981 |
Prazosin: a review of clinical experience in hypertension.
Topics: Adrenergic beta-Antagonists; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Diuretics; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Glomerular Filtration Rate; Humans; Hydralazine; Hypertension; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Prazosin; Quinazolines; Vascular Resistance | 1981 |
[Peripheral vasodilator agents in cardiology].
Topics: Clinical Trials as Topic; Coronary Vessels; Heart Failure; Hemodynamics; Humans; Hydralazine; Myocardial Infarction; Nitrates; Nitroglycerin; Nitroprusside; Phentolamine; Piperazines; Prazosin; Quinazolines; Vasodilator Agents | 1980 |
Vasodilator therapy of congestive heart failure.
Topics: Aortic Valve Insufficiency; Captopril; Dobutamine; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Minoxidil; Mitral Valve Insufficiency; Nitroglycerin; Nitroprusside; Phentolamine; Physical Exertion; Piperazines; Prazosin; Quinazolines; Time Factors; Vasodilator Agents | 1980 |
[Peripheral vasodilators in the treatment of heart failure].
Topics: Cardiac Output; Cardiomyopathies; Coronary Circulation; Droperidol; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nitrates; Nitroprusside; Phentolamine; Piperazines; Prazosin; Quinazolines; Rheumatic Heart Disease; Stroke Volume; Vasodilator Agents | 1982 |
Medicalisation of race.
Topics: Age Distribution; Aged; Antineoplastic Agents; Black or African American; Clinical Trials as Topic; Drug Approval; Drug Combinations; Gefitinib; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Lung Neoplasms; Middle Aged; Patents as Topic; Quinazolines; United States; United States Food and Drug Administration | 2007 |
18 trial(s) available for quinazolines and hydralazine
| Article | Year |
|---|---|
Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension.
Topics: Animals; Benzothiadiazines; Blood Pressure; Clinical Trials as Topic; Diuretics; Drug Eruptions; Drug Therapy, Combination; Heart Rate; Humans; Hydralazine; Hypertension; Kidney; Kidney Diseases; Kinetics; Methyldopa; Prazosin; Quinazolines; Renin; Sodium Chloride Symporter Inhibitors; Time Factors | 1977 |
Vasodilators in the treatment of hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Benzothiadiazines; Clinical Trials as Topic; Diazoxide; Diuretics; Drug Therapy, Combination; Female; Furans; Humans; Hydralazine; Hypertension; Male; Minoxidil; Piperazines; Quinazolines; Sodium Chloride Symporter Inhibitors; Vasodilator Agents | 1975 |
Changing concepts in the management of hypertension.
Topics: Adrenergic beta-Antagonists; Aged; Animals; Benzothiadiazines; Clinical Trials as Topic; Clonidine; Diazoxide; Diet, Sodium-Restricted; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Methyldopa; Piperazines; Quinazolines; Reserpine; Vasodilator Agents | 1975 |
Studies with prazosin--a new effective hypotensive agent. II. Two double-blind cross-over studies comparing the effects of prazosin and hydrallazine.
Topics: Adult; Chlorothiazide; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Prazosin; Propranolol; Quinazolines | 1977 |
Studies with prazosin--a new effective hypotensive agent. III. An acute double-blind cross-over study comparing the effects of single doses of prazosin and hydrallazine in combination with propranolol and a diuretic.
Topics: Adult; Aged; Benzothiadiazines; Blood Pressure; Clinical Trials as Topic; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Posture; Prazosin; Propranolol; Pulse; Quinazolines; Sodium Chloride Symporter Inhibitors | 1978 |
A cross-over study between hydrallazine and prazosin.
Topics: Clinical Trials as Topic; Humans; Hydralazine; Hypertension; Prazosin; Propranolol; Quinazolines | 1976 |
Prazosin and hydrallazine in the treatment of hypertension.
Topics: Heart Rate; Humans; Hydralazine; Hypertension; Prazosin; Quinazolines; Time Factors | 1976 |
Letter: Prazosin in treatment of hypertension.
Topics: Humans; Hydralazine; Hypertension; Male; Piperazines; Propranolol; Quinazolines | 1975 |
Letter: Prazosin and hydrallazine in the treatment of hypertension.
Topics: Antihypertensive Agents; Clinical Trials as Topic; Furans; Humans; Hydralazine; Hypertension; Piperazines; Quinazolines | 1974 |
Hydralazine and prazosin in the treatment of hypertension.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydralazine; Hypertension; Male; Middle Aged; Prazosin; Quinazolines | 1983 |
Double-blind comparison of dihydralazine and prazosin in hypertensive patients on the diuretic-reserpine regimen.
Topics: Adult; Aged; Clinical Trials as Topic; Dihydralazine; Double-Blind Method; Female; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Norepinephrine; Prazosin; Quinazolines; Renin; Reserpine; Triamterene | 1981 |
Peripheral vasodilatation in the treatment of hypertension. Prazosin compared with hydralazine in patients not responding to beta-receptor blockade.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Prazosin; Propranolol; Quinazolines; Random Allocation; Vasodilator Agents | 1982 |
[Peripheral vasodilator agents in cardiology].
Topics: Clinical Trials as Topic; Coronary Vessels; Heart Failure; Hemodynamics; Humans; Hydralazine; Myocardial Infarction; Nitrates; Nitroglycerin; Nitroprusside; Phentolamine; Piperazines; Prazosin; Quinazolines; Vasodilator Agents | 1980 |
[Cross-over trial with Peripress (prazosin) and Apresolin (hydralazin), both in combination with beta-blocker].
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Cross-Sectional Studies; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Prazosin; Propranolol; Pulse; Quinazolines | 1980 |
Comparison of prazosin with hydralazine in patients receiving hydrochlorothiazide. A randomized, double-blind clinical trial.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prazosin; Pulse; Quinazolines; Random Allocation | 1981 |
Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study.
Topics: Aged; Captopril; Coronary Disease; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Prazosin; Proline; Quinazolines | 1982 |
Double-blind cross-over comparison of hydralazine and prazosin in hypertensive subjects on a beta-adrenoceptor blocking agent (atenolol).
Topics: Atenolol; Double-Blind Method; Drug Therapy, Combination; Humans; Hydralazine; Hypertension; Prazosin; Propanolamines; Quinazolines | 1980 |
[Orally active vasodilators in the management of chronic treatment-resistant cardiac failure (author's transl)].
Topics: Adult; Aged; Dihydralazine; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Middle Aged; Prazosin; Quinazolines | 1980 |
35 other study(ies) available for quinazolines and hydralazine
| Article | Year |
|---|---|
Adverse drug reactions during treatment of hypertension.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Clonidine; Drug Interactions; Humans; Hydralazine; Male; Methyldopa; Middle Aged; Piperazines; Practolol; Quinazolines | 1976 |
Diseases of the cardiovascular system Hypertension--II.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Bethanidine; Clonidine; Debrisoquin; Diazoxide; Drug Therapy, Combination; Guanethidine; Humans; Hydralazine; Methyldopa; Phytotherapy; Piperazines; Plants, Medicinal; Quinazolines; Rauwolfia | 1976 |
Hydrallazine and prazosin.
Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Humans; Hydralazine; Hypertension; Prazosin; Quinazolines | 1978 |
Unimpaired beta adrenergic responses during prazosin administration.
Topics: Blood Glucose; Blood Pressure; Dopamine beta-Hydroxylase; Heart Rate; Humans; Hydralazine; Hypertension; Insulin; Prazosin; Quinazolines; Receptors, Adrenergic; Receptors, Adrenergic, beta; Renin | 1979 |
Hypotensive agents. Part I: Vasodilators.
Topics: Diazoxide; Humans; Hydralazine; Hypertension; Prazosin; Quinazolines | 1979 |
Comparison of the in vitro effects of prazosin, nifedipine, and dihydralazine in isolated human mesenteric and crural vessels.
Topics: Adolescent; Adult; Aged; Calcium; Dihydralazine; Humans; Hydralazine; In Vitro Techniques; Leg; Mesenteric Arteries; Mesenteric Veins; Middle Aged; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nifedipine; Norepinephrine; Potassium; Prazosin; Pyridines; Quinazolines | 1979 |
Comparison of haemodynamic effects of oral hydralazine and prazosin hydrochloride in patients with chronic congestive heart failure.
Topics: Adult; Aged; Cardiac Output; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Prazosin; Quinazolines; Vascular Resistance | 1979 |
Comparison of haemodynamic effects of oral prazosin, oral hydralazine, and intravenous nitroprusside in same patients with chronic heart failure.
Topics: Adult; Aged; Chronic Disease; Ferricyanides; Heart Failure; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Nitroprusside; Prazosin; Quinazolines | 1979 |
[Dihydralazin versus prazosin. The hemodynamic effect of the modul substances (author's transl)].
Topics: Animals; Blood Pressure; Cardiac Output; Cardiovascular System; Dihydralazine; Dogs; Heart Rate; Heart Ventricles; Hydralazine; Myocardial Contraction; Prazosin; Quinazolines; Stimulation, Chemical; Time Factors; Vascular Resistance | 1977 |
Hydralazine-induced tachycardia and sodium retention in heart failure. Hemodynamic and symptomatic correction by prazosin therapy.
Topics: Aged; Coronary Disease; Digitalis Glycosides; Female; Furosemide; Heart Failure; Humans; Hydralazine; Nitroprusside; Prazosin; Quinazolines; Sodium; Tachycardia | 1978 |
[Peripheral vasodilators in the treatment of hypertension. A review].
Topics: Drug Therapy, Combination; Humans; Hydralazine; Hypertension; Prazosin; Quinazolines | 1979 |
Mechanism of the hypotensive action of prazosin.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Diazoxide; Dose-Response Relationship, Drug; Drug Interactions; Epinephrine; Heart Rate; Hydralazine; Indoramin; Norepinephrine; Pentolinium Tartrate; Phentolamine; Prazosin; Quinazolines; Rats | 1977 |
A comparsion of the effects of prazosin and hydrallazine on blood pressure, heart rate and plasma renin activity in conscious renal hypertensive dogs.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Dogs; Furans; Hydralazine; Hypertension, Renal; Male; Piperazines; Quinazolines; Radioimmunoassay; Renin | 1975 |
Analysis of the hypotensive action of prazosin.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cardiac Output; Cats; Dogs; Drug Interactions; Electric Stimulation; Female; Heart Rate; Hemodynamics; Hydralazine; Hypertension, Renal; In Vitro Techniques; Male; Piperazines; Posture; Quinazolines; Rabbits; Rats; Regional Blood Flow; Time Factors; Vascular Resistance | 1975 |
[Hypotensive effect and tolerability of a short course of treatment with prazosin (pratsiol) and hydralazine (apressin) in a cooperative study of new drugs for the prevention of arterial hypertension].
Topics: Adult; Drug Therapy, Combination; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prazosin; Quinazolines; Time Factors | 1985 |
Combined prazosin and hydralazine in resistant hypertension.
Topics: Adult; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Posture; Prazosin; Quinazolines | 1980 |
New approaches to managing congestive heart failure.
Topics: Captopril; Heart Failure; Humans; Hydralazine; Prazosin; Proline; Quinazolines | 1983 |
Chronic afterload reduction in the treatment of congestive heart failure.
Topics: Captopril; Drug Evaluation; Heart Failure; Humans; Hydralazine; Prazosin; Proline; Quinazolines | 1983 |
Vasodilators and ventricular septal defect: comparison of prazosin, minoxidil, and hydralazine in a chronic lamb model.
Topics: Animals; Blood Pressure; Heart Rate; Heart Septal Defects, Ventricular; Hydralazine; Minoxidil; Prazosin; Pulmonary Circulation; Pyrimidines; Quinazolines; Sheep; Vascular Resistance; Vasodilation | 1984 |
A review of the long-term effects of prazosin and hydralazine in chronic congestive heart failure.
Topics: Chronic Disease; Drug Therapy, Combination; Follow-Up Studies; Heart Failure; Humans; Hydralazine; Nitrates; Prazosin; Quinazolines; Spironolactone; Time Factors | 1983 |
Prostaglandin synthesis by vascular smooth muscle cells is stimulated by bradykinin, prazosin and hydralazine.
Topics: Animals; Aorta; Bradykinin; Cells, Cultured; Dinoprostone; Guinea Pigs; Hydralazine; Muscle, Smooth, Vascular; Prazosin; Prostaglandins; Prostaglandins E; Quinazolines | 1981 |
The addition of prazosin to standard triple therapy in the treatment of severe hypertension.
Topics: Adult; Aged; Bendroflumethiazide; Blood Pressure; Drug Therapy, Combination; Electrocardiography; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Prazosin; Propranolol; Quinazolines | 1982 |
Correlation between decreased heart rate and central inhibition of sympathetic discharge after prazosin administration in the spontaneously hypertensive rat.
Topics: Animals; Blood Pressure; Cardiovascular System; Heart Rate; Hydralazine; Hypertension; Male; Prazosin; Quinazolines; Rats; Sympathetic Nervous System | 1981 |
Dynamic responses to continuous use of prazosin and hydralazine in patients with refractory heart failure.
Topics: Aged; Blood Pressure; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Prazosin; Quinazolines; Vascular Resistance | 1981 |
Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose.
Topics: Cardiac Output; Dose-Response Relationship, Drug; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Kidney; Liver Circulation; Male; Middle Aged; Prazosin; Quinazolines; Regional Blood Flow; Vascular Resistance | 1981 |
New therapies in the management of congestive heart failure.
Topics: Heart Failure; Humans; Hydralazine; Prazosin; Quinazolines | 1980 |
Metabolic assessment of exercise in chronic heart failure patients treated with short-term vasodilators.
Topics: Adult; Aged; Cardiac Output; Energy Metabolism; Heart Failure; Hemodynamics; Humans; Hydralazine; Lactates; Middle Aged; Myocardium; Oxygen Consumption; Physical Exertion; Prazosin; Quinazolines | 1980 |
Beneficial effects of afterload reduction therapy in patients with congestive heart failure and moderate aortic stenosis.
Topics: Adult; Aged; Aortic Valve Stenosis; Blood Pressure; Cardiac Output; Female; Heart Failure; Heart Rate; Humans; Hydralazine; Male; Middle Aged; Prazosin; Quinazolines; Stroke Volume; Vascular Resistance; Vasodilator Agents | 1980 |
Vasodilator therapy of chronic congestive heart failure.
Topics: Ambulatory Care; Chronic Disease; Heart Failure; Humans; Hydralazine; Nitrates; Prazosin; Quinazolines | 1980 |
Effect of vasodilator drugs on exercise performance in cardiac failure. Comparison of hydralazine and prazosin.
Topics: Adult; Aged; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Oxygen Consumption; Physical Exertion; Prazosin; Quinazolines; Respiration | 1980 |
Positive inotropic effects of hydralazine in human subjects: comparison with prazosin in the setting of congestive heart failure.
Topics: Dose-Response Relationship, Drug; Heart Failure; Heart Rate; Humans; Hydralazine; Myocardial Contraction; Prazosin; Pulmonary Wedge Pressure; Quinazolines; Stroke Volume | 1980 |
Suppression of mesangial proliferative glomerulonephritis development in rats by inhibitors of cAMP phosphodiesterase isozymes types III and IV.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Actins; Animals; Blood Pressure; Calcium-Calmodulin-Dependent Protein Kinases; Glomerulonephritis, Membranoproliferative; Hydralazine; Isoenzymes; Kidney Function Tests; Kidney Glomerulus; Laminin; Male; Phosphodiesterase Inhibitors; Proteinuria; Pyrrolidinones; Quinazolines; Rats; Rats, Wistar; Rolipram; Superoxides | 1996 |
The renin-angiotensin and adrenergic nervous system in cardiac hypertrophy in fructose-fed rats.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Catecholamines; Diet; Fructose; Glucose Tolerance Test; Heart Rate; Hydralazine; Hyperinsulinism; Hypertrophy, Left Ventricular; Imidazoles; Insulin; Male; Myocardium; Olmesartan Medoxomil; Organ Size; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Renin-Angiotensin System; Sympathetic Nervous System; Tetrazoles | 2002 |
Drug targeting: is race enough?
Topics: Asian People; Black or African American; Drug Combinations; Drug Industry; ErbB Receptors; Gefitinib; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Pharmacogenetics; Quinazolines; United States; United States Food and Drug Administration | 2005 |
BiDil raises questions about race as a marker.
Topics: Biomarkers; Black People; Clinical Trials as Topic; Dihydropyrimidine Dehydrogenase Deficiency; Dihydrouracil Dehydrogenase (NADP); Drug Approval; Drug Combinations; Drug Interactions; ErbB Receptors; Erlotinib Hydrochloride; Fluorouracil; Gefitinib; Heart Failure; Humans; Hydralazine; Isosorbide; Middle Aged; Mutation; National Institutes of Health (U.S.); Polymorphism, Genetic; Quinazolines; Risk Factors; Socioeconomic Factors; Treatment Outcome; United States; Uracil; White People | 2005 |